UPDATE: Piper Jaffray Upgrades Vertex Pharmaceuticals Ahead Of Expected Combination Approvals
UPDATE: Piper Jaffray Initiates Coverage on Endocyte on Multiple Drivers at Attractive Valuation
UPDATE: Piper Jaffray Downgrades Sarepta Therapeutics After FDA Reverses View on Eteplirsen NDA Filing
UPDATE: Piper Jaffray Initiates Coverage on Acceleron Pharma on Promising Anemia and Cancer Play
Edward A. Tenthoff Recent News
UPDATE: Piper Jaffray Upgrades Osiris Therapeutics, Pull-Back Offers Attractive Entry Point
UPDATE: Piper Jaffray Raises PT on Regeneron Pharmaceuticals Following Presentation of EYLEA DME Data
UPDATE: Piper Jaffray Downgrades Achillion Pharmaceuticals as Pipeline Setback Pushes Out Approval
UPDATE: Piper Jaffray Downgrades Osiris Therapeutics on DFU Data
UPDATE: Piper Jaffray Initiates XOMA at Overweight on 'Xciting Antibody Play'
UPDATE: Piper Jaffray Initiates OncoMed Pharmaceuticals at Overweight on Emerging Cancer Antibody Play
UPDATE: Piper Jaffray Raises PT on Alnylam Pharmaceuticals Following R&D Day
Piper Jaffray Reiterates Overweight Rating on Novavax on Initiation of Phase I H7N9 Avian Flu Study
UPDATE: Piper Jaffray Upgrades Regeneron Pharmaceuticals to Overweight Following EYLEA Launch
UPDATE: Piper Jaffray Raises PT on Arena Pharmaceuticals on Strong Belviq Survey